EUVIMEDEUVIMED entdecken
Crossref

The APOE ε2 Allele Increases the Risk of Earlier Age at Onset in Machado-Joseph Disease

Conceição Bettencourt, Mafalda Raposo, Nadiya Kazachkova, Teresa Cymbron, Cristina Santos, Teresa Kay, João Vasconcelos, Patrícia Maciel, Karina C Donis, Maria Luiza Saraiva-Pereira, Laura B Jardim, Jorge Sequeiros und 1 weitere

Archives of Neurology · 01.12.2011 · 68 (12) · 1580

DOI: 10.1001/archneurol.2011.636 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Neurology, erschienen am 01.12.2011. Verfasst von Conceição Bettencourt und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center of Research in Natural Resources and Department of Biology, University of Azores, Rua Mãe de Deus-Apartado 1422, 9501-801 Ponta Delgada, Azore…. Hauptthemen laut MEDLINE: Alleles. Die Arbeit wurde bisher 38-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To investigate a modulating effect of the apolipoprotein E (APOE) polymorphism on age at onset of Machado-Joseph disease (MJD). DESIGN: We collected blood samples from 192 patients with MJD and typed the APOE polymorphism. Patients The 192 patients with MJD included 59 from the Azores, 73 from mainland Portugal, and 60 from Brazil. SETTING: Academic research center. RESULTS: Cases with the ε2/ε3 genotype had an earlier onset compared with those with the ε3/ε3 or the ε3/ε4 genotype. In this series of patients, the presence of an APOE ε2 allele implies a decrease of nearly 5 years in the age at onset. When combining several other predictors in a general linear model, namely, the presence/absence of the APOE ε2 allele, with the size of the (CAG)(n) in expanded alleles, the model was significantly improved and the explanation of onset variance was raised from 59.8% to 66.5%. Furthermore, the presence of the ε2 allele was associated with an onset before age 39 years (odds ratio, 5.00; 95% CI, 1.18-21.14). CONCLUSION: The polymorphism at the APOE gene plays a role as a genetic modifier of MJD phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AllelesAdolescentAdultAge of OnsetAgedApolipoprotein E2ChildEarly DiagnosisFemaleGenotypeHumansMachado-Joseph DiseaseMaleMiddle AgedPhenotypePolymorphism, GeneticRiskYoung Adult

Substanzen

Apolipoprotein E2

Autor:innen und Institutionen

  • Center of Research in Natural Resources and Department of Biology, University of Azores, Rua Mãe de Deus-Apartado 1422, 9501-801 Ponta Delgada, Azores, Portugal. mcbettencourt@uac.pt

Zitieren

APA

Bettencourt, C., Raposo, M., Kazachkova, N., Cymbron, T., Santos, C., Kay, T., Vasconcelos, J., Maciel, P., Donis, K. C., Saraiva-Pereira, M. L., Jardim, L. B., Sequeiros, J., & Lima, M. (2011). The APOE ε2 Allele Increases the Risk of Earlier Age at Onset in Machado-Joseph Disease. Archives of Neurology, 68(12), 1580. https://doi.org/10.1001/archneurol.2011.636

Vancouver

Bettencourt C, Raposo M, Kazachkova N, Cymbron T, Santos C, Kay T, et al. The APOE ε2 Allele Increases the Risk of Earlier Age at Onset in Machado-Joseph Disease. Archives of Neurology. 2011;68(12):1580. doi:10.1001/archneurol.2011.636

BibTeX
@article{Bettencourt2011,
  author = {Bettencourt, Conceição and Raposo, Mafalda and Kazachkova, Nadiya and Cymbron, Teresa and Santos, Cristina and Kay, Teresa and Vasconcelos, João and Maciel, Patrícia and Donis, Karina C and Saraiva-Pereira, Maria Luiza and Jardim, Laura B and Sequeiros, Jorge and Lima, Manuela},
  title = {The APOE ε2 Allele Increases the Risk of Earlier Age at Onset in Machado-Joseph Disease},
  journal = {Archives of Neurology},
  year = {2011},
  volume = {68},
  number = {12},
  pages = {1580},
  doi = {10.1001/archneurol.2011.636}
}
Kostenlos starten →